MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Effect of Levodopa-Carbidopa Intestinal Gel Versus Optimized Medical Treatment on Dyskinesia in Advanced Parkinson’s Disease Patients: Final Results of the Randomized 12-Week DYSCOVER Study

    E.F Alvarez, C. Spanaki, E. Pekkonen, L. Manzanares, Y. Liu, O. Sánchez-Soliño, L. Barbato (Elche, Spain)

    Objective: This study evaluated the effectiveness of LCIG versus optimized medical treatment (OMT) on the duration and severity of dyskinesia in aPD patients. Background: Approximately…
  • MDS Virtual Congress 2020

    Blood-Brain Barrier Opening with Focused Ultrasound in Parkinson´s Disease with Cognitive Impairment: A Safety and Feasibility Study

    C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, R. Rodríguez-Rojas, F. Hernández, I. Obeso, M. del Álamo, P. Guida, D. Mata-Marin, R. Martínez-Fernández, C. Ordás-Bandera, G. Foffani, I. Rachmilevitch, J. Obeso (Móstoles, Spain)

    Objective: To evaluate the safety and feasibility of MR guided focused ultrasound (MRgFUS) blood-brain barrier (BBB) opening in the cortex or the striatum in Parkinson´s…
  • MDS Virtual Congress 2020

    Serious games home rehabilitation program to treat gait and balance disorders in patients with Parkinson’s disease: A randomised controlled trial

    D. Nuic, S. de Weijer, E. Zeeboer, C. Olivier, S. Cherif, P. Foulon, B.R Bloem, N. De Vries, M.L Welter (Paris, France)

    Objective: To test the efficacy of an exergame rehabilitation programme at home to treat dopa-resistant gait and balance disorders in Parkinson’s disease (PD) patients. Background:…
  • MDS Virtual Congress 2020

    Deep Brain Stimulation impact on Social and Occupational Function in Parkinson’s Disease with Early Motor Complications

    V. Stoker, P. Krack, L. Tonder, A. Schnitzler, J.L Houeto, J. Rau, C. Schade-Brittinger, M. Vidailhet, G. Deuschl (Minneapolis, MN, USA)

    Objective: To investigate the effect of DBS compared with BMT on social, psychosocial and occupational functioning in PD patients ≤ 60 years of age with…
  • MDS Virtual Congress 2020

    A Parkinson’s disease dog providing therapeutic intervention in Parkinson’s disease

    C. Buckley, B. O'Callaghan, J. Dowler, N. Austin, E. Reynolds, M. Lowery, T. Lynch (Dublin 7, Ireland)

    Objective: To report a case of Parkinson’s disease gait impairment which responded favourably to intervention with an assistance dog. Background: Gait abnormalities including freezing of…
  • MDS Virtual Congress 2020

    High Satisfaction and Improved Quality of Life with Rock Steady Boxing in Parkinson’s Disease

    D. Larson, D. Bega, M. Rafferty, C. Yeh (Chicago, IL, USA)

    Objective: To compare demographics, self-reported symptom burden, Health-Related Quality of Life (HRQL), and Exercise Self-Efficacy (ESE) between Rock Steady Boxing (RSB) participants and non-participants. Background:…
  • MDS Virtual Congress 2020

    Sensor-Based Gait Measurements Predict Subthalamic Deep Brain Stimulation Frequency in Parkinson’s Disease Patients – A Proof of Concept Study

    J. Watts, A. Khojandi, O. Shylo, R. Ramdhani (Knoxville, TN, USA)

    Objective: To conduct a proof-of-concept study to demonstrate that objectively measured gait kinematics can predict the choice of subthalamic nucleus deep brain stimulation (STN-DBS) frequency…
  • MDS Virtual Congress 2020

    Risk Factors and Subtypes of Ischemic Stroke in Patients with Parkinson’s Disease

    M. Burzhunova, N. Garabova (Moscow, Russian Federation)

    Objective: To identify risk factors and TOAST pathogenic subtypes of ischemic stroke (IS) in patients with Parkinson's disease (PD) . Background: Several studies revealed a increased…
  • MDS Virtual Congress 2020

    Parkinsonism secondary to mercury poisoning in a Colombian population

    J. Vargas (Bogotá, Colombia)

    Objective: To describe the clinical and paraclinical characteristics of patients over 18 years of age who consulted the Neurology service of the University Hospital with…
  • MDS Virtual Congress 2020

    Beyond Parkinson’s disease: the use of standardized speech, physical and occupational therapies for PD in atypical parkinsonisms, other movement disorders and aging conditions

    C. Fox, L. Guse, A. Halpern (Tucson, AZ, USA)

    Objective: 1) Examine how speech, physical and occupational therapists are using evidence-based, Parkinson’s specific treatments (LSVT LOUD and LSVT BIG) in atypical parkinsonisms, other movement…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley